| Steven Riley Winham, DO | |
|
1710 W 3rd St, Elk City, OK 73644-5159 | |
| (580) 339-7540 | |
| Not Available |
| Full Name | Steven Riley Winham |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 1710 W 3rd St, Elk City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871971341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 6073 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Plains Home Care | Elk city, OK | Home health agency |
| Encompass Health Home Health Of Western Oklahoma | Weatherford, OK | Home health agency |
| Carter Healthcare Of Central Oklahoma, Llc | Oklahoma city, OK | Home health agency |
| Shepherd Home Health And Hospice, Llc | Clinton, OK | Home health agency |
| Great Plains Regional Medical Center | Elk city, OK | Hospital |
| Roger Mills Memorial Hospital | Cheyenne, OK | Hospital |
| Weatherford Regional Hospital, Inc Of Weatherford | Weatherford, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Farmers Union Hospital Association | 7517949415 | 37 |
News Archive
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The COVID-19 pandemic has prompted scientists at Cincinnati Children's Hospital Medical Center to pivot their suicide prevention research efforts with a focus on telehealth.
› Verified 9 days ago
| Entity Name | Farmers Union Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184639122 PECOS PAC ID: 7517949415 Enrollment ID: O20040603001383 |
News Archive
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The COVID-19 pandemic has prompted scientists at Cincinnati Children's Hospital Medical Center to pivot their suicide prevention research efforts with a focus on telehealth.
› Verified 9 days ago
| Entity Name | Mangum City Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033635263 PECOS PAC ID: 6305119942 Enrollment ID: O20181020000126 |
News Archive
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The COVID-19 pandemic has prompted scientists at Cincinnati Children's Hospital Medical Center to pivot their suicide prevention research efforts with a focus on telehealth.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Riley Winham, DO Po Box 2339, Elk City, OK 73648-2339 Ph: (580) 339-7540 | Steven Riley Winham, DO 1710 W 3rd St, Elk City, OK 73644-5159 Ph: (580) 339-7540 |
News Archive
A transformation in the treatment of patients with dementia is quietly taking place at the Lakeside Medical Unit at Johns Hopkins Bayview Medical Center. There, as part of a collaboration with researchers at the Hopkins School of Nursing (JHUSON), clinicians are putting into practice a protocol that can ease the most troublesome symptoms of dementia, not through drugs but with behavior therapy.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
Fate Therapeutics, Inc. announced today that the Company received Red Herring's North America 100 award, a prestigious list honoring the year's most promising private and innovative companies from the North American business region. The nominees were evaluated by the Red Herring editorial team on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy and integration into their respective industries.
The COVID-19 pandemic has prompted scientists at Cincinnati Children's Hospital Medical Center to pivot their suicide prevention research efforts with a focus on telehealth.
› Verified 9 days ago
John H True, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 W 1st St, Suite 107b, Elk City, OK 73644 Phone: 580-225-9988 Fax: 580-225-5423 |